Table 5.

Comparative analysis of intraoperative outcome and postoperative biochemical profile and outcome in the ‘livers that nobody wants’ (LNW) (n = 26) and control (n = 25) groups

	LNW group	Control group	P-value
Intraoperative outcome
Extubation in the ORa, n (%)	5 (19.2)	7 (26.9)	0.68
Biochemical profileb
Peak total bilirubin, mg/ml, median (range)	3.5 (0.9–14)	6.1 (1.5–25)	0.01
Peak ALT, U/l, median (range)	590 (163–4890)	590 (163–4890)	0.20
Peak AST, U/l, median (range)	533 (162–2870)	895 (240–17600)	0.19
Peak AST > 1500 U/l, n (%)	5 (19.2)	6 (24)	0.94
Prothrombin time < 50%, n (%)	13 (50)	12 (48)	1.00
Primary delayed function, n (%)	4 (15.3)	4 (16)	0.74
Postoperative outcome
Primary non-function, n (%)	1 (3.8)	1 (4)	0.48
Renal failurec, n (%)	2 (7.6)	1 (4)	0.97
Major complications, n (%)	4 (15.3)	5 (20)	0.94
ICU stay, days, median (range)	3 (1–12)	2 (1–27)	0.58
Hospital stay, days, median (range)	8 (5–33)	8 (4–47)	0.64
30-day mortality, n (%)	1 (3.8)	2 (8.0)	0.97
1-year patient survival rate	84%	84%	0.74
1-year graft survival rate	84%	80%	0.94

^aWithdrawal of mechanical ventilation in the operating room

^bPeak serum transaminases and total bilirubin or lower prothrombin time within the first week after liver transplant

^cRequiring haemodialysis or haemofiltration

OR, operating room; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ICU, intensive care unit